Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 5 studies | 30% ± 10% | |
| myofibroblast cell | 4 studies | 24% ± 8% | |
| mesothelial cell | 4 studies | 43% ± 14% | |
| type B pancreatic cell | 3 studies | 40% ± 16% | |
| epithelial cell | 3 studies | 22% ± 5% | |
| neuron | 3 studies | 40% ± 2% | |
| smooth muscle cell | 3 studies | 25% ± 7% | |
| pericyte | 3 studies | 26% ± 1% |
Insufficient scRNA-seq data for expression of LDOC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 2855.16 | 180 / 180 | 99% | 70.01 | 426 / 430 |
| thymus | 100% | 3744.92 | 651 / 653 | 99% | 70.17 | 598 / 605 |
| brain | 99% | 4102.20 | 2618 / 2642 | 97% | 39.71 | 682 / 705 |
| adrenal gland | 100% | 2114.68 | 257 / 258 | 96% | 53.67 | 221 / 230 |
| breast | 99% | 1895.11 | 453 / 459 | 96% | 40.20 | 1069 / 1118 |
| prostate | 99% | 2321.07 | 242 / 245 | 95% | 34.13 | 477 / 502 |
| kidney | 98% | 1972.16 | 87 / 89 | 93% | 22.00 | 841 / 901 |
| lung | 87% | 1207.22 | 505 / 578 | 71% | 20.03 | 820 / 1155 |
| bladder | 100% | 2096.00 | 21 / 21 | 47% | 13.15 | 235 / 504 |
| uterus | 99% | 3198.24 | 169 / 170 | 42% | 16.41 | 194 / 459 |
| esophagus | 96% | 1415.59 | 1385 / 1445 | 42% | 11.59 | 76 / 183 |
| skin | 99% | 2105.73 | 1794 / 1809 | 29% | 6.77 | 136 / 472 |
| pancreas | 55% | 496.73 | 181 / 328 | 72% | 14.53 | 129 / 178 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.00 | 1 / 1 |
| blood vessel | 100% | 11585.47 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 28.13 | 79 / 80 |
| adipose | 95% | 1681.54 | 1145 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 67% | 809.06 | 240 / 359 | 18% | 4.00 | 52 / 286 |
| spleen | 79% | 789.22 | 190 / 241 | 0% | 0 | 0 / 0 |
| intestine | 67% | 843.40 | 647 / 966 | 11% | 1.88 | 60 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 60% | 11.78 | 27 / 45 |
| heart | 29% | 268.36 | 248 / 861 | 0% | 0 | 0 / 0 |
| liver | 1% | 8.04 | 2 / 226 | 18% | 5.20 | 72 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.44 | 1 / 29 |
| muscle | 3% | 26.69 | 22 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 9.29 | 11 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0071222 | Biological process | cellular response to lipopolysaccharide |
| GO_0001893 | Biological process | maternal placenta development |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0060137 | Biological process | maternal process involved in parturition |
| GO_0071225 | Biological process | cellular response to muramyl dipeptide |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LDOC1 |
| Protein name | Protein LDOC1 (Leucine zipper protein down-regulated in cancer cells) Leucine zipper downregulated in cancer variant |
| Synonyms | BCUR1 |
| Description | FUNCTION: May have an important role in the development and/or progression of some cancers. |
| Accessions | ENST00000370526.5 E5L8F5 O95751 |
